CO1 A Balancing Act: Low-Dose Atropine Significantly Slows Pediatric Myopia Progression Without a Clinically Meaningful Risk of Rebound (Accelerated Myopia Progression Following Treatment Cessation)
Abstract
Authors
Jelena Jovanovic Maria Zacharioudaki Georgios Papadakis Marilena Kalatzi Nagarjuna Mulkalapalli Frederic Ernst Thom de Milliano